These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 8883529

  • 1. Comparison of iodixanol and ioxaglate for adult aortography and renal/visceral angiography: a phase III clinical trial.
    Siegel EL, Rosenblum JD, Eckard DA, Leef J, Bergh J, Parsa MB, Redick ML.
    Acad Radiol; 1996 Sep; 3 Suppl 3():S507-13. PubMed ID: 8883529
    [Abstract] [Full Text] [Related]

  • 2. Iodixanol and ioxaglate in adult aortography and peripheral arteriography: a phase III clinical trial.
    Rosenblum JD, Siegel EL, Leef J, Eckard DA, Lu CT.
    Acad Radiol; 1996 Sep; 3 Suppl 3():S514-8. PubMed ID: 8883530
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Iodixanol and ioxaglate in cardioangiography: a double-blind randomized phase III study.
    Andersen PE, Bolstad B, Berg KJ, Justesen P, Thayssen P, Kloster YF.
    Clin Radiol; 1993 Oct; 48(4):268-72. PubMed ID: 8243006
    [Abstract] [Full Text] [Related]

  • 6. Renal toxicity evaluation and comparison between visipaque (iodixanol) and hexabrix (ioxaglate) in patients with renal insufficiency undergoing coronary angiography: the RECOVER study: a randomized controlled trial.
    Jo SH, Youn TJ, Koo BK, Park JS, Kang HJ, Cho YS, Chung WY, Joo GW, Chae IH, Choi DJ, Oh BH, Lee MM, Park YB, Kim HS.
    J Am Coll Cardiol; 2006 Sep 05; 48(5):924-30. PubMed ID: 16949481
    [Abstract] [Full Text] [Related]

  • 7. Iodixanol in cardioangiography. A double-blind parallel comparison between iodixanol 320 mg I/ml and ioxaglate 320 mg I/ml.
    Tveit K, Bolz KD, Bolstad B, Haugland T, Berg KJ, Skjaerpe T, Kloster YF.
    Acta Radiol; 1994 Nov 05; 35(6):614-8. PubMed ID: 7946687
    [Abstract] [Full Text] [Related]

  • 8. Randomized trial of contrast media utilization in high-risk PTCA: the COURT trial.
    Davidson CJ, Laskey WK, Hermiller JB, Harrison JK, Matthai W, Vlietstra RE, Brinker JA, Kereiakes DJ, Muhlestein JB, Lansky A, Popma JJ, Buchbinder M, Hirshfeld JW.
    Circulation; 2000 May 09; 101(18):2172-7. PubMed ID: 10801758
    [Abstract] [Full Text] [Related]

  • 9. Ionic low-osmolar versus nonionic iso-osmolar contrast media to obviate worsening nephropathy after angioplasty in chronic renal failure patients: the ICON (Ionic versus non-ionic Contrast to Obviate worsening Nephropathy after angioplasty in chronic renal failure patients) study.
    Mehran R, Nikolsky E, Kirtane AJ, Caixeta A, Wong SC, Teirstein PS, Downey WE, Batchelor WB, Casterella PJ, Kim YH, Fahy M, Dangas GD.
    JACC Cardiovasc Interv; 2009 May 09; 2(5):415-21. PubMed ID: 19463464
    [Abstract] [Full Text] [Related]

  • 10. Iodixanol in leg phlebography: a randomized, double-blind parallel group phase III trial comparing iodixanol to ioxaglate.
    Sapoval MR, Beyssen BM, Girardot C, Musset MA, Legmann P, Brekke O, Gaux JC.
    Clin Radiol; 1996 Mar 09; 51(3):210-3. PubMed ID: 8605753
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Effect of iodixanol on renal function immediately after abdominal angiography. Clinical comparison with iomeprol and ioxaglate.
    Murakami R, Tajima H, Kumazaki T, Yamamoto K.
    Acta Radiol; 1998 Jul 09; 39(4):368-71. PubMed ID: 9685820
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Cardiac events after low osmolar ionic or isosmolar nonionic contrast media utilization in the current era of coronary angioplasty.
    Le Feuvre C, Batisse A, Collet JP, Batisse JP, Choussat R, Beygui F, Helft G, Montalescot G, Metzger JP.
    Catheter Cardiovasc Interv; 2006 Jun 09; 67(6):852-8. PubMed ID: 16649230
    [Abstract] [Full Text] [Related]

  • 15. Early and late reactions after the use of iopamidol 340, ioxaglate 320, and iodixanol 320 in cardiac catheterization.
    Sutton AG, Finn P, Grech ED, Hall JA, Stewart MJ, Davies A, de Belder MA.
    Am Heart J; 2001 Apr 09; 141(4):677-83. PubMed ID: 11275937
    [Abstract] [Full Text] [Related]

  • 16. Renal failure in 57 925 patients undergoing coronary procedures using iso-osmolar or low-osmolar contrast media.
    Liss P, Persson PB, Hansell P, Lagerqvist B.
    Kidney Int; 2006 Nov 09; 70(10):1811-7. PubMed ID: 17003814
    [Abstract] [Full Text] [Related]

  • 17. Vectorcardiographic changes during cardioangiography with iodixanol and ioxaglate.
    Flinck A, Selin K.
    Int J Cardiol; 2000 Nov 09; 76(2-3):173-80. PubMed ID: 11104872
    [Abstract] [Full Text] [Related]

  • 18. Phase III clinical trial comparing iodixanol and iohexol in cerebral angiography.
    Poirier VC, Newberry PD, Hecht ST, Nemzek WR.
    Acad Radiol; 1996 Sep 09; 3 Suppl 3():S495-9. PubMed ID: 8883527
    [Abstract] [Full Text] [Related]

  • 19. Immediate and late adverse reactions in coronary angiography. A comparison between iodixanol and ioxaglate.
    Fransson SG, Stenport G, Andersson M.
    Acta Radiol; 1996 Mar 09; 37(2):218-22. PubMed ID: 8600966
    [Abstract] [Full Text] [Related]

  • 20. Renal effects of low and isoosmolar contrast media on renal hemodynamic in a normal and ischemic dog kidney.
    Deray G, Bagnis C, Jacquiaud C, Dubois M, Adabra Y, Jaudon C.
    Invest Radiol; 1999 Jan 09; 34(1):1-4. PubMed ID: 9888047
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.